S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

Guggenheim - Analyst Performance

This page shows the methodology used to calculate Guggenheim's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the brokerage, the stock's actual performance 12 months from the date the research note was issued. These calculations are based on research reports from 12/6/2018 and 12/6/2022. Rankings are updated daily.

MarketBeat Brokerage Ranking: starstarxxx
Average 12-Month ROI of Buy Recommendations: ??%
Export to Excel
CompanyReport DateReport Date Price12-Month
Price Target		Rating12-Month
Actual Price		12-Month
ROI		Details

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

Already have an account? Log in here.



How are MarketBeat's Brokerage Rankings Calculated? MarketBeat uses the average return on investment of a research firm's "buy" and "strong buy" recommendations over the last five years to determine a firm's star rating. The firms with the best-performing recommendations receive a five-star rating. Firms that have issued fewer than ten tracked research notes in the last five years will not be ranked.

Return to Brokerage Rankings

My Account -